What's Driving the In Vitro Diagnostics Industry through 2020 and Beyond?--Alternative Scenarios of the Future IVD Market: Business-as-Usual, Economic Austerity, Technological Breakthroughs

Publisher Name :
Date: 10-Oct-2016
No. of pages: 255
Price : Single User: US $ 14500  US $ 11600 Corporate User: US $ 29300  US $ 23440
This report is available at 20% Discount till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

This new report is designed to help executives develop effective contingency plans that best accommodate uncertainties ahead. The study objectives include:

  • To identify and evaluate emerging markets and technologies that may present unexpected threats or offer opportunities.
  • To identify key strategic decisions that will have to be made in the future.
  • To enhance corporate ability to develop realistic contingency plans.
  • To prepare executives to accommodate radically different operating climates and reduce surprises.
  • To challenge accepted perceptions of the future diagnostics market.
  • This report is an invaluable strategic planning resource for corporate, marketing and R&D executives. The strategic issues explored in the report include:

    - How will the future reimbursement changes affect individual market segments?

    - Will the industry consolidate, decentralize, or undergo a bimodal transformation?

    - What will be the impact on purchasing influences, marketing strategies, joint ventures, mergers,

    licensing, import and export?

    - How will the future technological advances affect the major market segment?

    - Which companies will enter the market and which will not survive?

    These and other key issues facing the decision-makers are explored in this thought-provoking and multi-faceted portrait of the three possible futures and their strategic implication. We would be glad to answer any questions you might have regarding this informative, comprehensive and insightful market research and technology assessment report, and look forward to your subscription.

    Contains 255 pages and 32 tables

     

    This report is available at 20% Discount till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

    What's Driving the In Vitro Diagnostics Industry through 2020 and Beyond?--Alternative Scenarios of the Future IVD Market: Business-as-Usual, Economic Austerity, Technological Breakthroughs

    Table of Contents

    Recommendations
    IV.The Scenarios
    A. Business-As-Usual Scenario
    1. Business Environment
    a. Health Care Expenditures
    b. Cost-Consciousness
    c. Reimbursement
    d. Industry Consolidation
    e. Managed Care
    - PPOs
    - HMOs
    f. Hospitals
    g. Admissions
    h. Length of Stay
    i. Industry Diversification
    j. Physician Demographics
    k. Aging Population
    - Chronic Illnesses
    - Disease Incidence
    - Susceptibility to Iatrogenesis
    - Multiple Illness Cases
    l. Laboratory Regulations
    m. The FDA Reform
    2. Outlook for the In Vitro Diagnostics Market
    a. Government Regulations
    b. Centralized Testing
    - Hospitals
    - Commercial Laboratories
    - Blood Banks
    - Public Health Laboratories
    c. Decentralized Testing
    - Personal Testing
    - Physician Offices/Group Practices - Ancillary Hospital Locations
    - ERs
    - ORs
    - ICUs/CCUs
    - Cancer Clinics
    - Ambulatory Care Centers - Surgery Centers - Nursing Homes - Birth Centers 3. Strategic Implications
    a. Testing Patterns
    - Test Utilization
    - Pre-Admission Testing
    - Inpatient Testing
    - Outpatient Testing
    4. Market Segments
    a. Chemistry and Immunoassay
    - Introduction
    - Future Situation
    b. Microbiology and Serology
    - Introduction
    - Future Situation
    c. Hematology and Flow Cytometry
    - Introduction
    - Future Situation
    d. Histology and Cytology
    - Introduction
    - Future Situation
    e. Coagulation
    - Introduction
    - Future Situation
    f. Urinalysis
    - Introduction
    - Future Situation
    g. Blood Banking
    - Introduction
    - Future Situation
    5.Technologies
    a. Genomics
    - Introduction
    - Future Situation
    b. Proteomics
    - Introduction
    - Future Situation
    c. DNA Probes
    - Introduction
    - Future Situation
    d. Biochips/Microarrays
    - Introduction
    - Future Situation
    e. Monoclonal Antibodies
    - Introduction
    - Future Situation
    f. Solid Phase Chemistry
    - Introduction
    - Future Situation
    g. Biosensors
    - Introduction
    - Future Situation
    h. Automation and Robotics
    - Introduction
    - Future Situation
    i. Computer-Aided Diagnosis
    - Introduction
    - Future Situation
    6.The New Marketplace
    a. Purchasing Influences
    b. Marketing Strategies
    c. Joint Ventures, Mergers and Licensing
    d. Import-Export
    e. Potential Market Entrants
    f. Who May Not Survive?
    B. Economic Austerity Scenario
    1. Business Environment
    a. Socio-Political Climate
    - Cost-Consciousness
    - Government Actions
    - Three-Tier System
    - Health Rationing
    - Voucher System
    - Health IRA
    b. Hospital Closures
    c. Hospital Utilization
    d. Hospital Reorganization
    e. Physician Regulations
    f. Wellness Programs
    g. Corporate Responses
    h. Academic Research
    2. Outlook for the In Vitro Diagnostics Market
    a. Test Utilization
    - Ordering Practices
    - Documentation
    - Recertification
    b.Technology Regulations
    c. New Laboratory Ventures
    d. Computers
    e. Industrial Medicine
    f. Insurance Companies
    g. Test Volume and Market Size
    3. Strategic Implications
    a. Testing Patterns
    - Pre-Admission Testing
    - Inpatient Testing
    - Outpatient Testing
    b. Market Segments
    - Chemistry and Immunoassay
    - Microbiology and Serology
    - Hematology and Flow Cytometry
    - Histology and Cytology
    - Coagulation
    - Urinalysis
    - Blood Banking
    c.Technologies
    - Genomics
    - Proteomics
    - DNA Probes
    - Biochips/Microarrays
    - Monoclonal Antibodies and Immunoassays
    - Automation and Robotics
    - Solid Phase Chemistry
    - Biosensors
    - Computer-Aided Diagnosis
    d.The New Marketplace
    - Purchasing Influences
    - Marketing Strategies
    - Joint Ventures, Mergers and Licensing
    - Import-Export
    - Potential Market Entrants
    - Who May Not Survive?
    C.Technological Breakthroughs Scenario
    1. Business Environment
    a. Political/Regulatory Climate
    b. R & D Funding
    c. Industry-Government Relationship
    d. Industry-University Ventures
    e.Technological Environment
    f. Testing Decentralization
    g. Health Care Expenditures
    h. Physician Population
    i. Hospital Indicators
    2. Outlook for the In Vitro Diagnostics Market
    a. Overview
    b. Genomics
    c. Proteomics
    d. DNA and RNA Probes
    e. Biochips/Microarrays
    f. Monoclonal Antibodies
    g. Immunoassays
    h. Information Technology
    i. Laboratory Automation and Robotics
    j. Solid Phase Chemistry
    k. Biosensors
    l. Holography
    m. Pharmaceuticals
    3. Strategic Implications
    a.Testing Patterns
    - Pre-Admission Testing
    - Inpatient Testing
    - Outpatient Testing
    - Test Volume and Market Size
    b. Market Segments
    - Chemistry and Immunoassay
    - Microbiology and Serology
    - Hematology and Flow Cytometry
    - Histology and Cytology
    - Coagulation
    - Urinalysis
    - Blood Banking
    c.The New Marketplace
    - Purchasing Influences
    - Marketing Strategies
    - Joint Ventures, Mergers and Licensing
    - Import-Export
    - Potential Market Entrants
    - Who May Not Survive?
    V. Appendices: Methodology
    A.The Delphi
    B. Cross-Impact Analysis
    C. Substitution Modeling

    List of Tables

    Executive Summary Table I: Business-As-Usual Scenario, Growth Areas in Clinical Laboratory Testing
    Executive Summary Table II: Economic Austerity Scenario, Growth Areas in Clinical Laboratory Testing
    Executive Summary Table III: Technological Breakthroughs Scenario, Growth Areas in Clinical Laboratory Testing
    Executive Summary Table IV: Market Size by Location
    Executive Summary Table V: Market Size by Laboratory Discipline
    Table-1: Business-As-Usual Scenario, Health Care Costs by Expenditure Type
    Table-2: Business-As-Usual Scenario, HMO and PPO Enrollment
    Table-3: Business-As-Usual Scenario, Selected Hospital Statistics
    Table-4: Business-As-Usual Scenario,Total Population and Physician Demographics
    Table-5: Business-As-Usual Scenario,Test Volume by Location
    Table-6: Business-As-Usual Scenario,Test Distribution by Location
    Table-7: Business-As-Usual Scenario, Market Size by Location
    Table-8: Business-As-Usual Scenario,Typical Pre-Admission Tests
    Table-9: Business-As-Usual Scenario,Test Volume by Laboratory Discipline
    Table-10: Business-As-Usual Scenario, Market Size by Laboratory Discipline
    Table-11: Economic Austerity Scenario, Selected Hospital Statistics
    Table-12: Economic Austerity Scenario, HMO and PPO Enrollment
    Table-13: Economic Austerity Scenario,Total Population and Physician Demographics
    Table-14: Economic Austerity Scenario, Major Categories of Overutilized Tests
    Table-15: Economic Austerity Scenario, Test Volume by Location
    Table-16: Economic Austerity Scenario,Test Distribution by Location
    Table-17: Economic Austerity Scenario, Market Size by Location
    Table-18: Economic Austerity Scenario,Timing Requirements for Selected Laboratory Tests
    Table-19: Economic Austerity Scenario,Test Volume by Laboratory Discipline
    Table-20: Economic Austerity Scenario, Market Size by Laboratory Discipline
    Table-21: Technological Breakthroughs Scenario, HMO and PPO Enrollment
    Table-22: Technological Breakthroughs Scenario,Total Population and Physician Demographics
    Table-23: Technological Breakthroughs Scenario, Selected Hospital Statistics
    Table-24: Technological Breakthroughs Scenario, Test Volume by Location
    Table-25: Technological Breakthroughs Scenario, Test Distribution by Location
    Table-26: Technological Breakthroughs Scenario, Market Size by Location
    Table-27: Technological Breakthroughs Scenario, Test Volume by Laboratory Discipline
    Table-28: Technological Breakthroughs Scenario, Market Size by Laboratory Discipline
  • Therapeutic Drug Monitoring (TDM) Market 2021: US, Europe, Japan--Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 8500 Onwards        Pages: 0
    Complete report $8,500. DataPack (test volumes, sales forecasts, supplier shares) $5,500.This new 313-page report from VPGMarketResearch.com contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and m......
  • France Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Pr......
  • Germany Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 249-page report from VPGMarketResearch.com provides a comprehensive analysis of the German therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Pr......
  • Italy Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the Italian therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/P......
  • Japan Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2750 Onwards        Pages: 0
    This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the Japanese therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/......
  • Spain Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation ReviewReview
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 249-page report from VPGMarketResearch.com provides a comprehensive analysis of the Spanish therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/P......
  • UK Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the UK therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Proca......
  • US Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 3500 Onwards        Pages: 0
    This new 249-page report from VPGMarketResearch.com provides a comprehensive analysis of the US therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procai......
  • Endocrine Function Diagnostics Market 2021: US, Europe, Japan--Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation
    Published: 15-Nov-2017        Price: US 8500 Onwards        Pages: 0
    Complete report $8,500. DataPack (test volumes, sales forecasts, supplier shares) $5,500.This new 327-page report from VPGMarketResearch.com contains 75 tables and provides analysis of the global endocrine function diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs